SAMHD1 Research Digest — 2026-08-12¶
Generated by samhd1_monitor | Model: claude-sonnet-5
Summary: 8 papers evaluated | 1 high-relevance (≥7) | 3 medium (5–6) | 4 low (3–4) | 0 scored <3
🔴 High Relevance (Score 7–10)¶
Auto-added to Zotero (threshold ≥6)
PEG3 inhibits mitophagy of papillary thyroid carcinoma through ISG15/VCP axis (from Oncology (thyroid carcinoma))
Bing Wang; Jing Yao; Zheng Wan; Xin Miao; Zelong Yang — Cellular and Molecular Life Sciences 2026
Score: 7/10 | Pathways: ISG15-mitophagy, treatment-target
This paper directly demonstrates ISG15 binding to and stabilizing VCP to promote mitophagy, providing mechanistic support for the RED pathway (ISG15-mediated mitophagy blockade) in the SAMHD1 interferon-mitochondrial syndrome model, though in a cancer rather than interferonopathy context.
DOI: 10.1007/s00018-026-06368-x
🟡 Medium Relevance (Score 5–6)¶
Score ≥6 auto-added to Zotero; lower scores: review manually
Cholesterol Drives IFITM3+ Microglia Activation and Induces STING Mediated Neuroinflammation After Ischemic Stroke. (from Neurology/stroke)
Cheng Yue; Zhou Yuxi; Chen Yonghui; Shen Tianni; Li Yan — CNS neuroscience & therapeutics 2026
Score: 6/10 | Pathways: cGAS-STING, NLRP3, treatment-target
This paper demonstrates mitochondrial DNA leakage driving STING-mediated NLRP3 inflammasome activation in microglia via cholesterol-induced IFITM3+ activation, directly paralleling the BLUE/PURPLE loop mechanism (mtDNA fragments → cGAS/STING → inflammation) and using pharmacological STING inhibition (C-176, analogous to therapeutic targets in the SAMHD1 pathway) as a treatment strategy relevant to interferonopathy management.
DOI: 10.1002/cns.71073
cGAS-STING targeting offers a novel therapeutic paradigm in hemorrhagic stroke. (from Neurology/stroke)
Wang Yu; Dou Lidong; Gao Ying; Zhang Ming; Wang Zhiji — Tissue & cell 2026
Score: 6/10 | Pathways: cGAS-STING, NLRP3, treatment-target
Reviews cGAS-STING/mtDNA-driven neuroinflammation and NLRP3 activation with pharmacological inhibitors (RU.521, H-151), directly relevant to the BLUE loop mechanism though in a distinct clinical context (hemorrhagic stroke rather than SAMHD1 interferonopathy).
DOI: 10.1016/j.tice.2026.103851
The Role of SAMHD1 in Viral Resistance and Transduction Efficiency Challenges in Pediatric Hematological Malignancies: Mechanistic Insights and Clinical Perspectives. (from Pediatric hematology-oncology / gene therapy)
Alzamzami Waseem — European journal of haematology 2026
Score: 6/10 | Pathways: dNTPase, gene-therapy-delivery, treatment-target, clinical-phenotype
Reviews SAMHD1 dNTPase biology, viral restriction (Vpx), and lentiviral gene therapy transduction barriers relevant to gene correction strategies, though focused on pediatric leukemia rather than A565T haploinsufficiency or interferon-mitochondrial mechanism.
DOI: 10.1111/ejh.70027
🟢 Low Relevance (Score 3–4)¶
Potential specialty bridges — skim titles
From xanthine oxidase inhibition to inflammasome regulation: exploring the potential role of allopurinol in TXNIP-NLRP3 signaling and pyroptosis in diabetes. (from Endocrinology/diabetes pharmacology)
Qamar Faiz; Parveen Ramsha; Vaseem Mohd; Ahmad Tufail; Vohora Divya — Inflammopharmacology 2026
Score: 4/10 | Pathways: NLRP3, urate-NLRP3
Reviews xanthine oxidase/TXNIP-NLRP3 pyroptosis in diabetes—touches the GOLD (uric acid-NLRP3) axis conceptually but is disease-context (diabetes) rather than SAMHD1/interferonopathy-driven and offers no mitochondrial dNTP or IFN-I linkage.
DOI: 10.1007/s10787-026-02354-8
Establishment of a scalable engineered cell-line platform for direct, GMP-grade production of eVLP vectors enabling streamlined generation of gene-edited CAR-T/NK cells. (from cell and gene therapy manufacturing/bioengineering)
Lin Wei; Shi Jiaru; Chen Hanyi; Chai Ruikai; Zhu Sha — Frontiers in immunology 2026
Score: 4/10 | Pathways: gene-therapy-delivery
This paper describes an eVLP-based manufacturing platform for CAR-T/NK gene editing, which is only tangentially related to SAMHD1 mechanisms but shares the eVLP delivery technology category noted as relevant to future gene correction strategies.
DOI: 10.3389/fimmu.2026.1878099
Highly efficient CRISPR editing enabled by magnetic nanoparticle delivery. (from biomedical engineering/genome editing methodology)
Go Inkyung; Lee Seung Hwan — Frontiers in genome editing 2026
Score: 3/10 | Pathways: gene-therapy-delivery
This paper describes a general improvement in CRISPR delivery efficiency (magnetofection) without any immune/myeloid-cell specificity, SAMHD1 relevance, or disease pathway connection, making it only tangentially useful as a generic gene-editing delivery method.
DOI: 10.3389/fgeed.2026.1865675
PIWI-piRNA Axis in Epilepsy: Bridging Epigenetic Regulation, Neuroinflammation, and Neuronal Excitability. (from Neurology (epilepsy/epigenetics))
Shyam Mukul; Rashmi Rashmi; Sharma Vidhi; Venkatesh Rajendran; Jain Aditi — Molecular neurobiology 2026
Score: 3/10 | Pathways: NLRP3, other
Discusses NLRP3/TLR4-NF-kB in epilepsy via piRNA epigenetics, a tangential mechanistic overlap but unrelated to SAMHD1, mitochondrial dNTP biology, or interferonopathy, and epilepsy is not a documented family phenotype.
DOI: 10.1007/s12035-026-06103-4
Pathway Coverage This Week¶
treatment-target: 4 papersNLRP3: 4 papersgene-therapy-delivery: 3 paperscGAS-STING: 2 papersISG15-mitophagy: 1 papersdNTPase: 1 papersclinical-phenotype: 1 papersurate-NLRP3: 1 papersother: 1 papers